Case Report
Published on 30 Jul 2024
Case report: Dual-targeted BCMA and CS1 CAR-T-cell immunotherapy in recurrent and refractory extramedullary multiple myeloma
in Cancer Immunity and Immunotherapy

- 2,142 views
- 1 citation
Case Report
Published on 30 Jul 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Jul 2024
in Cancer Immunity and Immunotherapy
Review
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Review
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Review
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Review
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Case Report
Published on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Review
Published on 25 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 25 Jul 2024
in Cancer Immunity and Immunotherapy